Clinical Trial Update: Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating cetuximab for metastatic penile squamous cell carcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Penile Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Centre Leon Berard | Conditions: Squamous Cell Carcinoma of the Penis | Phase 2 | Status: WITHDRAWN